Salary ranges · Netherlands · free

Pharmacist salary in Amsterdam, 2026

Core range €55 to 80k a year at 3 to 7 years; €45k to €100k across the published market. Estimate built between published anchors, labelled and reviewed.

ExperienceLow outlierCore rangeHigh outlier
0 to 2 years€32k€42 to 55k€70k
3 to 7 years€45k€55 to 80k€100k
8 to 15 years€65k€80 to 110k€140k

Not in the list? Type the city or the title anyway. Published survey data first; anything else is labelled as an estimate built from published anchors. Searching is free, it just needs an account.

Pharmacist · Amsterdam, Netherlands · 3 to 7 years

Core range €55 to 80k a year

Built from published survey anchors · 2026-09-27
€45k
Low outlier: part-time positions at small independent pharmacies
€55 to 80k
Core range, where most offers land
€100k
High outlier: chain managers, hospital heads, pharma industry
City vs national hub
Amsterdam pay tends to be above national average for regulated healthcare roles.
Statistics Netherlands (CBS) 2023
Employer-type premium
Hospital and large-chain employers pay materially more than small independent pharmacies.
Hays Netherlands Salary Guide 2024
Skill and qualification premium
Registered pharmacists and specialists command higher core bands than assistants.
KNMP salary guidance 2022
Typical annual increase
Typical contractual increases are 2 to 4% annually in healthcare.
Hays Netherlands Salary Guide 2024
Sources: Statistics Netherlands (CBS), Wages by occupation (2023); Hays Netherlands Salary Guide (2024); KNMP, Royal Dutch Pharmacists Association salary guidance (2022). This range is interpolated between the published survey rows either side of it and reviewed before it is promoted to verified; a figure outside the published market is never shown. Ask inside the core; use the outliers to spot a low offer or a real niche premium.
Every role, every city, all 28 countries, side by side, with negotiation scripts. In Pro, or open one country's full bands for ₹99.
See Pro

Part of the EDZER Job Market. Every figure carries its source; nothing is invented.